Axogen, Inc. (AXGN) News

Axogen, Inc. (AXGN): $9.98

-0.34 (-3.29%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter AXGN News Items

AXGN News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

AXGN News Highlights

  • AXGN's 30 day story count now stands at 4.
  • Over the past 8 days, the trend for AXGN's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
  • The most mentioned tickers in articles about AXGN are META.

Latest AXGN News From Around the Web

Below are the latest news stories about AXOGEN INC that investors may wish to consider to help them evaluate AXGN as an investment opportunity.

Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2022

ALACHUA, Fla. and TAMPA, Fla., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced preliminary unaudited fourth quarter and full-year 2022 revenue. Preliminary Unaudited Fourth Quarter and Year-End Performance and Business Highlights Fourth quarter revenue is expected to be approximately $36.1 million, a 16% increase compared to fourth-quarter 2021 excluding the imp

Yahoo | January 9, 2023

Axogen Announces Independent Publication of Comparative Nerve Gap Repair Meta-Analysis of 35 peer-reviewed studies of Allograft, Autograft, and Conduits

Study concluded allograft and autograft repairs delivered significantly better rates of meaningful sensory recovery in short gaps as compared to conduit repairs in a systematic meta-analysis including over 1,500 nerve repairs across 35 studiesALACHUA, Fla. and TAMPA, Fla., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced the independent publication of a comprehen

Yahoo | January 5, 2023

Axogen to Participate at J.P. Morgan 41st Annual Healthcare Conference

ALACHUA, Fla. and TAMPA, Fla., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that Karen Zaderej, chairman, CEO, and president, will present at the JP Morgan 41st Annual Healthcare Conference in San Francisco. The presentation is scheduled for Thursday, January 12, 2023 at 9:45 a.m. PST (12:45 p.m. EST). The presentation will be webcast live and accessible thro

Yahoo | January 4, 2023

AxoGen, Inc. (NASDAQ:AXGN) is favoured by institutional owners who hold 65% of the company

Every investor in AxoGen, Inc. ( NASDAQ:AXGN ) should be aware of the most powerful shareholder groups. And the group...

Yahoo | January 1, 2023

Axogen Patient to Ride the 2023 Donate Life Rose Parade® Float Supporting awareness of organ and tissue donation

ALACHUA, Fla. and TAMPA, Fla., Dec. 19, 2022 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that Bri Majsiak, a Resensation ® patient, has been selected to ride on the 2023 Donate Life Rose Parade Float and Madelyn Nicpon will be honored at this year’s event through a floragraph that will adorn the float. The Tournament of Roses ® parade takes place on January 2, 2023 in Pasadena. This is the tenth year Axogen has co-sponsored the Donate Life float to help raise awareness for the importance of organ and tissue donation.

GlobeNewswire | December 19, 2022

Axogen Patient to Ride the 2023 Donate Life Rose Parade Float Supporting awareness of organ and tissue donation

ALACHUA, Fla. and TAMPA, Fla., Dec. 19, 2022 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that Bri Majsiak, a Resensation patient, has been selected to ride on the 2023 Donate Life Rose Parade Float and Madelyn Nicpon will be honored at this year’s event through a floragraph

Wallstreet:Online | December 19, 2022

Axogen Patient to Ride the 2023 Donate Life Rose Parade® Float Supporting awareness of organ and tissue donation

ALACHUA, Fla. and TAMPA, Fla., Dec. 19, 2022 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that Bri Majsiak, a Resensation® patient, has been selected to ride on the 2023 Donate Life Rose Parade Float and Madelyn Nicpon will be honored at this year’s event through a floragraph that will adorn the float. The Tournament of Roses® parade takes place on January 2, 2023 in Pasad

Yahoo | December 19, 2022

AxoGen Stock: Rally Potentially Exhausted, Revise To Hold (NASDAQ:AXGN)

We believe there may be downside risk in AxoGen looking ahead. Read more to see why we think AXGN''s rally may have exhausted and why we''re revising our rating.

Seeking Alpha | December 9, 2022

How did AxoGen Inc. (AXGN) fare last session?

The share price of AxoGen Inc. (NASDAQ:AXGN) rose to $10.95 per share on Wednesday from $10.48. While AxoGen Inc. has overperformed by 4.48%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, AXGN rose by 14.42%, with highs and lows ranging from $13.66 to $6.87, whereas the […]

US Post News | December 1, 2022

Here's Why "Trend" Investors Would Love Betting on AxoGen (AXGN)

If you are looking for stocks that are well positioned to maintain their recent uptrend, AxoGen (AXGN) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

Yahoo | November 11, 2022


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6462 seconds.